PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory for Stem Cells and Reproductive Cell Biology, Department of Histology and Embryology, Ankara University Faculty of Medicine, Ankara, Turkey.\', \'Harvard Medical School, Boston, Massachusetts, USA.\', \'Department of Cardiology, Boston Children\'s Hospital, Boston, Massachusetts, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/sctm.20-0164
?:hasPublicationType
?:journal
  • Stem cells translational medicine
is ?:pmid of
?:pmid
?:pmid
  • 32779878
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.722
?:rankingScore_hIndex
  • 45
is ?:relation_isRelatedTo_publication of
?:title
  • The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32779878>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32779878>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all